Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc by-nc-nd (c) Otero Torres, Sara et al., 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/214570

DPYD genotyping and 5-fluoropyrimidine toxicity: An overview of systematic reviews protocol

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Introduction: The increased risk of severe and life -threatening toxicity in patients with dihydropyridine dehydrogenase (DPD) deficiency, under treatment with fluoropyrimidines, has been widely studied. An up-to-date overview of systematic reviews summarizing existing literature can add value by highlighting most relevant information and supports decision -making regarding treatment in DPD deficient patients. The main objective of this overview of systematic reviews is to identify published systematic reviews on the association between germline variations in the DPYD gene and fluoropyrimidine toxicity. Methods and analysis: This protocol was developed following the Preferred Reported Items for Systematic Review and Meta -analysis Protocols (PRISMA-P) checklist, and the overview of systematic reviews will be reported in accordance with the PRISMA statement. PubMed, Embase, Scopus, and the Cochrane Library will be searched from inception to 2023. Systematic reviews irrespective of study designs that analyze the association between germline variations in the DPYD and fluoropyrimidine toxicity will be considered. Methodological quality will be assessed using AMSTAR2 checklist (Measurement Tool to Assess Systematic Reviews 2). Two independent investigators will perform the study selection, quality assessment, and data collection. Discrepancies will be solved by a third investigator. Registration details: Registration number in PROSPERO: CRD42023401226. (c) 2023 Sociedad Espa & ntilde;ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa & ntilde;a, S.L.U. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Citació

Citació

OTERO TORRES, Sara, MONTERO PÉREZ, Olalla, RODRÍGUEZ MAURIZ, Rosa, FORT CASAMARTINA, Eduard, FONTANALS MARTÍNEZ, Sandra, CLOPÉS ESTELA, Ana. DPYD genotyping and 5-fluoropyrimidine toxicity: An overview of systematic reviews protocol. _Farmacia Hospitalaria_. 2024. Vol. 48, núm. 2, pàgs. 79-82. [consulta: 20 de gener de 2026]. ISSN: 2171-8695. [Disponible a: https://hdl.handle.net/2445/214570]

Exportar metadades

JSON - METS

Compartir registre